J. Buritova et al., KETOPROFEN PRODUCES PROFOUND INHIBITION OF SPINAL C-FOS PROTEIN EXPRESSION RESULTING FROM AN INFLAMMATORY STIMULUS BUT NOT FROM NOXIOUS HEAT, Pain, 67(2-3), 1996, pp. 379-389
This study assesses the anti-inflammatory/analgesic effects of ketopro
fen a non-steroidal anti-inflammatory drug, using the method of c-Fos
immunoreactivity at the spinal cord level in two models of noxious sti
mulation: carrageenan-induced inflammatory pain or acute noxious heat.
Ketoprofen was pre-administered intravenously or orally 25 min before
an intraplantar injection of carrageenan (6 mg in 150 mu l of saline)
in hindpaw of the non-anaesthetised rat or before a single noxious he
at (52 degrees C, 15 sec) stimulation of hindpaw of the anaesthetised
rat. Three hours after carrageenan or 2 h after noxious heat, the numb
er of spinal c-Fos protein-like immunoreactive (c-Fos-LI) neurons in L
4-L5 segments and both the ankle and paw diameter, the indicator of pe
ripheral oedema, were assessed. Pre-administered ketoprofen (1, 3 and
10 mg/kg i.v.) dose-dependently blocks the development of the carragee
nan-induced spinal c-Fos protein expression and peripheral oedema, wit
h the highest dose influencing in parallel both parameters (75 +/- 2%
diminution of total number of c-Fos-LI neurons per L4-L5 section; 64 /- 4% and 82 +/- 6% diminution of paw and ankle oedema, respectively).
The effect of ketoprofen was significantly greater on the number of c
-Fos-LI neurons in deep, as compared to superficial, laminae. Furtherm
ore, the dose-dependent effects of ketoprofen on the carrageenan-induc
ed spinal c-Fos protein expression and both the paw and ankle oedema w
ere correlated, Oral pre-administration of ketoprofen (20 mg/kg) produ
ced the blockage of development of the carrageenan-induced spinal c-Fo
s protein expression (65 +/- 3% diminution of total number of c-Fos-LI
neurons per L4-L5 section) and peripheral oedema (20 +/- 3% and 59 +/
- 10% diminution of paw and ankle oedema, respectively). In contrast,
the same doses of both the intravenous and oral pre-administration of
ketoprofen did not influence either the spinal c-Fos protein expressio
n nor slightly enhanced paw diameter induced by a single noxious heat
stimulation. This study suggests a predominant peripheral site, withou
t excluding a central site of action of ketoprofen in the carrageenan-
induced inflammation. The method of c-Fos protein-like immunoreactivit
y revealed ketoprofen to be more potent in comparison to members of ot
her families of non-steroidal anti-inflammatory drugs, previously stud
ied in the same experimental conditions of carrageenan-induced inflamm
atory pain.